Literature DB >> 26945542

Percutaneous exclusion of a rapidly enlarging left main coronary artery aneurysm using coils and an Amplatzer™ septal occluder.

Vikas Aggarwal1, Gregory Mishkel2, Nilesh Goswami3.   

Abstract

Coronary artery aneurysms (CAAs) are often an incidental finding amongst patients undergoing coronary angiography. Most CAAs are managed conservatively; rarely a larger CAA can lead to intramural thrombus formation and coronary artery embolization/obstruction even without the presence of significant stenosis. Despite these clinical implications, therapeutic options are limited to case reports and no clearly defined guidelines have been established for treatment. In this article, we present a unique case of a rapidly enlarging left main CAA, with no identifiable etiology that was treated with percutaneous exclusion via coil embolization and an Amplatzer™ septal occluder device. We also discuss existing literature, pathophysiology, and management options for CAAs.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  coronary artery aneurysm; mycotic aneurysm; septal occluder

Mesh:

Year:  2016        PMID: 26945542     DOI: 10.1002/ccd.26478

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  1 in total

1.  Rationale and design of a multicenter, international and collaborative Coronary Artery Aneurysm Registry (CAAR).

Authors:  Iván J Núñez-Gil; Luis Nombela-Franco; Rodrigo Bagur; Mario Bollati; Enrico Cerrato; Emilio Alfonso; Christoph Liebetrau; José María De la Torre Hernandez; Benjamín Camacho; Rafael Mila; Ignacio J Amat-Santos; Fernando Alfonso; Ramón Rodríguez-Olivares; Santiago J Camacho Freire; Íñigo Lozano; Víctor Alfonso Jiménez Díaz; Davide Piraino; Roberto Adriano Latini; Gisela Feltes; Jose Antonio Linares; Massimo Mancone; Alfonso Ielasi; Alejandro Sánchez-Grande Flecha; Agustín Fernández Cisnal; Fabrizio Ugo; Jesús M Jiménez Mazuecos; Pierluigi Omedè; Marco Pavani; Pedro A Villablanca; Boshra F Louka; Antonio Fernández-Ortiz
Journal:  Clin Cardiol       Date:  2017-03-24       Impact factor: 2.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.